Evidence map›Paper›PMID 34203215›Full record

ArticleCancers2021

Knockout of Putative Tumor Suppressor Aldh1l1 in Mice Reprograms Metabolism to Accelerate Growth of Tumors in a Diethylnitrosamine (DEN) Model of Liver Carcinogenesis.

Natalia I Krupenko, Jaspreet Sharma, Halle M Fogle, Peter Pediaditakis, Kyle C Strickland, Xiuxia Du, Kristi L Helke, Susan Sumner, Sergey A Krupenko

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 23 citations in OpenAlex.

  1. ALDH1L1 reverses CD8Journal of translational medicine · 2026
    Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. ALDH1L2 drives HCC progression through TAM polarization.JHEP reports : innovation in hepatology · 2025
    Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Natalia I KrupenkoDepartment of Nutrition, University of North Carolina, Chapel Hill, NC 27599, USA.
Jaspreet SharmaNutrition Research Institute, University of North Carolina, Kannapolis, NC 28081, USA.ORCID 0000-0003-4777-7805
Halle M FogleNutrition Research Institute, University of North Carolina, Kannapolis, NC 28081, USA.
Peter PediaditakisNutrition Research Institute, University of North Carolina, Kannapolis, NC 28081, USA.
Kyle C StricklandDepartment of Pathology, Duke University, Durham, NC 27708, USA.
Xiuxia DuDepartment of Bioinformatics & Genomics, UNC Charlotte, Charlotte, NC 28223, USA.
Kristi L HelkeDepartment of Comparative Medicine, Medical University of South Carolina, Charleston, SC 29425, USA.
Susan SumnerDepartment of Nutrition, University of North Carolina, Chapel Hill, NC 27599, USA.
Sergey A KrupenkoDepartment of Nutrition, University of North Carolina, Chapel Hill, NC 27599, USA.ORCID 0000-0002-6926-2776
David H. Murdock Research Institute · USUniversity of North Carolina at Chapel Hill · USDuke University · USMedical University of South Carolina · USUniversity of North Carolina at Charlotte · US

Funding

UNIV OF NORTH CAROLINA CLINICAL NUTRITION RESEARCH UNITP30DK056350 · NIDDK · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Venkata Saroja Voruganti · 1999 to 2026
$31.6M
FDH: A Novel Determinant of Tumor SuppressionR01CA095030 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI KRUPENKO, SERGEY A · 2005 to 2014
$2.5M
NCI NIH HHS R01 CA095030NIDDK NIH HHS P30 DK056350
6 · The paper itself

Abstract

Cytosolic 10-formyltetrahydrofolate dehydrogenase (ALDH1L1) is commonly downregulated in human cancers through promoter methylation. We proposed that ALDH1L1 loss promotes malignant tumor growth. Here, we investigated the effect of the

Indexed as

ALDH1L1diethylnitrosamine (DEN) carcinogenesisfolate metabolismliver cancermetabolomicsmouse knockout

Identifiers

PMID34203215
PMCPMC8268287
OpenAlexW3175993431

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.